Expressive Writing Intervention Study
Promoting Well-Being Through Identity Affirmation and Social Connection in TNB Adults: An Expressive Writing Intervention
3 other identifiers
interventional
117
1 country
1
Brief Summary
This study aims to test to what extent an expressive writing intervention may reduce internalized anti-TNB (trans and nonbinary) stigma and promote well-being over time. Trans and/or nonbinary people may take part in this study, and can expect to participate for 3 months.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Sep 2023
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 2, 2023
CompletedFirst Posted
Study publicly available on registry
March 24, 2023
CompletedStudy Start
First participant enrolled
September 8, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 21, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
June 18, 2024
CompletedSeptember 19, 2024
September 1, 2024
9 months
March 2, 2023
September 4, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (6)
Assess the feasibility of expressive writing intervention through qualitative data
Collect open-ended text responses to the following question: Considering the logistical and practical side of this study, what was your experience like completing the writing tasks this last week? For example, did you find it easy or challenging to write for the full 20 minutes each session? How was it writing using the device that you did, such as writing in Word and uploading to Qualtrics or writing directly in Qualtrics?
One week post-baseline
Assess the feasibility of expressive writing intervention by recording the number of attended writing sessions for each participant.
Analyze any differences in number of attended writing sessions for participants by condition, with each participants' attendance score ranging from 0 (none) to 4 (all).
One week post-baseline
Assess the acceptability of expressive writing intervention through qualitative data
Collect open-ended text responses to the following question: Emotionally, what was your experience like completing the writing sessions this last week? Did you notice any changes in your emotional experience over the course of the week?
One week post-baseline
Effect of missed sessions on Positive and Negative Affect Scale (PANAS)
Participants' total scale scores to the Positive and Negative Affect Scale (PANAS), which can range from 10 to 50, with higher scores indicating greater positive affect (positive affect subscale) and lower scores indicating lower levels of negative affect (negative affect subscale), will be analyzed for their correlations with missed sessions and/or participant attrition, as documented through participant attendance scores, described above.
One week post-baseline
Assess the fidelity of expressive writing intervention
Analyze participants' writing to assess the degree to which intervention condition writing instructions were followed. Two members of the research team will assess participants' writing and code for the presence of emotion/affect-related words (yes=1, no=0), focus on gender identity (yes=1, no=0), and advice or encouragement offered (yes=1, no=0). Interrater agreement will be assessed.
One week post-baseline
Amount of time spent writing
To assess fidelity of intervention, participants will be asked to self-report how much time they spent writing each day. Qualtrics data will also be examined to assess how many minutes participants spent in the survey.
One week post-baseline
Secondary Outcomes (7)
Change in resilience as determined by scores on the Brief Resilience Scale (BRS)
Baseline to 3 months
Change in state of depression, anxiety, and stress as determined by their scores on the Depression, Anxiety, and Stress Scale
Baseline to 3 months
Change in psychological well-being
Baseline to 3 months
Effects of expressive writing intervention on mental health
Baseline to 3 months
Change in Gender Minority Stress and Resilience (GMSR)
Baseline to 3 months
- +2 more secondary outcomes
Study Arms (3)
TNB Identity Affirmation (IA) Condition
EXPERIMENTALParticipants in the IA only intervention condition will receive the same prompt for all four days of writing, a design used in expressive writing interventions to allow for deeper and continued reflection into specific thoughts and emotions.
IA + Strengthening Social Connections (SSC) Condition
EXPERIMENTALFor participants in the IA+SSC condition, participants will complete the IA intervention on the first three days. On the fourth day, participants will be directed to compose a brief letter.
Control Condition
EXPERIMENTALExpressive writing assignment, without prompts.
Interventions
Participants will read a vignette, which describes the experience and response of a young adult who experiences rejection from a close friend after a first disclosure of their gender identity. Participants will then be asked to write in response to three prompts: 1) identify expressions of internalized transphobia in the vignette character, 2) reflect on times the participant has experienced similar feelings, 3) identify thoughts and feelings that promote and support a positive and affirming identity in contrast to negative emotions and thoughts.
Participants in the control condition will be asked to write about the events of their day and thoughts and feelings that occurred in response to those events.
Participants will be directed to compose a brief letter of gratitude to an individual to whom they have not previously expressed gratitude, and who has provided meaningful and affirming support to them as a TNB person.
Eligibility Criteria
You may qualify if:
- years of age or older
- transgender or nonbinary
- access to a phone, computer, and/or device from which they can access the surveys and daily writing session tasks
- ability to read and write English
You may not qualify if:
- cisgender individuals
- self-reported severe levels of psychological distress
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Wisconsin
Madison, Wisconsin, 53705, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Elliot A Tebbe, PhD, LP
University of Wisconsin, Madison
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 2, 2023
First Posted
March 24, 2023
Study Start
September 8, 2023
Primary Completion
May 21, 2024
Study Completion
June 18, 2024
Last Updated
September 19, 2024
Record last verified: 2024-09
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, ICF, ANALYTIC CODE
- Time Frame
- Data will be made available for a period of 5 years post data collection.
- Access Criteria
- PhD prepared researcher, holds a current appointment in an institution of higher education.
Researchers may submit a written request to the PI to access de-identified data. The written request should include 1) a short background to describe rationale, 2) a description of the planned analysis, and 3) planned dissemination of findings. The PI reserves the right to approve or disapprove any request. Only de-identified survey data will be shared.